Temporal Artery Biopsy for Diagnosing Giant Cell Arteritis: A Ten-year Review

To assess the use of temporal artery biopsy (TAB) in diagnosing giant cell arteritis (GCA) and to evaluate patients' clinical and laboratory characteristics.

We conducted a retrospective chart review of patients with suspected GCA who underwent TAB and had complete workup in a tertiary center in Iran between 2008 and 2017. The 2016 American College of Rheumatology (ACR) revised criteria for early diagnosis of GCA were used for each patient for inclusion in this study.

The mean age of the 114 patients in this study was 65.54 $$ 10.17 years. The mean overall score according to the 2016 ACR revised criteria was 4.17 $$ 1.39, with 5.82 $$ 1.28 for positive biopsies and 3.88 $$ 1.19 for negative biopsies (p <0.001). Seventeen patients (14.9%) had a positive biopsy. Although the mean post-fixation specimen length in the biopsy-positive group (18.35 $$ 6.9 mm) was longer than that in the biopsy-negative group (15.62 $$ 8.4 mm), the difference was not statistically significant (P = 0.21). There was no statistically significant difference between the groups in terms of sex, serum hemoglobin, platelet count, and erythrocyte sedimentation rate. There were statistically significant differences between the biopsy-negative and biopsy-positive groups with respect to patients' age and C-reactive protein level (P $$ 001 and P = 0.012, respectively).

The majority of TABs were negative. Reducing the number of redundant biopsies is necessary to decrease workload and use of medical services. We suggest that the diagnosis of GCA should be dependent on clinical suspicion.